These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 32029743)

  • 1. Down syndrome.
    Antonarakis SE; Skotko BG; Rafii MS; Strydom A; Pape SE; Bianchi DW; Sherman SL; Reeves RH
    Nat Rev Dis Primers; 2020 Feb; 6(1):9. PubMed ID: 32029743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetic analysis of Down syndrome.
    Patterson D
    Hum Genet; 2009 Jul; 126(1):195-214. PubMed ID: 19526251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical aging in Down syndrome.
    Zigman WB
    Dev Disabil Res Rev; 2013; 18(1):51-67. PubMed ID: 23949829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome phenotypes: the consequences of chromosomal imbalance.
    Korenberg JR; Chen XN; Schipper R; Sun Z; Gonsky R; Gerwehr S; Carpenter N; Daumer C; Dignan P; Disteche C
    Proc Natl Acad Sci U S A; 1994 May; 91(11):4997-5001. PubMed ID: 8197171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mechanisms involved in the phenotype of Down syndrome.
    Patterson D
    Ment Retard Dev Disabil Res Rev; 2007; 13(3):199-206. PubMed ID: 17910086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YAC and cosmid FISH mapping of an unbalanced chromosomal translocation causing partial trisomy 21 and Down syndrome.
    Nadal M; Milà M; Pritchard M; Mur A; Pujals J; Blouin JL; Antonarakis SE; Ballesta F; Estivill X
    Hum Genet; 1996 Oct; 98(4):460-6. PubMed ID: 8792823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.
    Izzo A; Mollo N; Nitti M; Paladino S; Calì G; Genesio R; Bonfiglio F; Cicatiello R; Barbato M; Sarnataro V; Conti A; Nitsch L
    Mol Med; 2018 Mar; 24(1):2. PubMed ID: 30134785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
    Bartesaghi R; Guidi S; Ciani E
    Rev Neurosci; 2011; 22(4):419-55. PubMed ID: 21819263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental development and function in trisomy 21 and mouse models of Down syndrome: Clues for studying mechanisms underlying atypical development.
    Adams AD; Guedj F; Bianchi DW
    Placenta; 2020 Jan; 89():58-66. PubMed ID: 31683073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and epigenetic pathways in Down syndrome: Insights to the brain and immune system from humans and mouse models.
    Yu YE; Xing Z; Do C; Pao A; Lee EJ; Krinsky-McHale S; Silverman W; Schupf N; Tycko B
    Prog Brain Res; 2020; 251():1-28. PubMed ID: 32057305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of allelic differences in Down syndrome.
    Roper RJ; Hawley L; Goodlett CR
    Prog Brain Res; 2020; 251():29-54. PubMed ID: 32057311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down syndrome: searching for the genetic culprits.
    Lana-Elola E; Watson-Scales SD; Fisher EM; Tybulewicz VL
    Dis Model Mech; 2011 Sep; 4(5):586-95. PubMed ID: 21878459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient with partial trisomy 21 and 7q deletion expresses mild Down syndrome phenotype.
    Papoulidis I; Papageorgiou E; Siomou E; Oikonomidou E; Thomaidis L; Vetro A; Zuffardi O; Liehr T; Manolakos E; Vassilis P
    Gene; 2014 Feb; 536(2):441-3. PubMed ID: 24334122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome.
    Contestabile A; Benfenati F; Gasparini L
    Prog Neurobiol; 2010 May; 91(1):1-22. PubMed ID: 20097253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down syndrome--genetic and nutritional aspects of accompanying disorders.
    Mazurek D; Wyka J
    Rocz Panstw Zakl Hig; 2015; 66(3):189-94. PubMed ID: 26400113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and intellectual disability: insights from mouse models of Down syndrome.
    Ruparelia A; Pearn ML; Mobley WC
    Dev Disabil Res Rev; 2013; 18(1):43-50. PubMed ID: 23949828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterotrisomy, a significant contributing factor to ventricular septal defect associated with Down syndrome?
    Baptista MJ; Fairbrother UL; Howard CM; Farrer MJ; Davies GE; Trikka D; Maratou K; Redington A; Greve G; Njølstad PR; Kessling AM
    Hum Genet; 2000 Nov; 107(5):476-82. PubMed ID: 11140945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach.
    Abukhaled Y; Hatab K; Awadhalla M; Hamdan H
    J Neurol; 2024 Jan; 271(1):87-104. PubMed ID: 37561187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.